140 related articles for article (PubMed ID: 32243282)
1. BILATERAL SEROUS RETINAL DETACHMENT AND UVEITIS ASSOCIATED WITH PEMBROLIZUMAB TREATMENT IN METASTATIC MELANOMA.
de Vries EW; Schauwvlieghe AS; Haanen JB; de Hoog J
Retin Cases Brief Rep; 2022 Jul; 16(4):430-434. PubMed ID: 32243282
[TBL] [Abstract][Full Text] [Related]
2. Pembrolizumab-related Bilateral Ocular Hypotony, Uveitis, Cataracts, Exudative Retinal, and Choroidal Detachments: An Unusual Success Story.
Golash V; Almeida G
J Immunother; 2020; 43(9):283-285. PubMed ID: 32740318
[TBL] [Abstract][Full Text] [Related]
3. Bilateral multiple serous retinal detachments after treatment with nivolumab: a case report.
Miyamoto R; Nakashizuka H; Tanaka K; Wakatsuki Y; Onoe H; Mori R; Kawamura A
BMC Ophthalmol; 2020 Jun; 20(1):221. PubMed ID: 32513129
[TBL] [Abstract][Full Text] [Related]
4. Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma.
Wang W; Lam WC; Chen L
Cancer Immunol Immunother; 2019 Jan; 68(1):85-95. PubMed ID: 30311026
[TBL] [Abstract][Full Text] [Related]
5. Management of Chronic Hypotony Following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma.
Reid G; Lorigan P; Heimann H; Hovan M
Ocul Immunol Inflamm; 2019; 27(6):1012-1015. PubMed ID: 29672247
[No Abstract] [Full Text] [Related]
6. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
7. A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab.
Abu Samra K; Valdes-Navarro M; Lee S; Swan R; Foster CS; Anesi SD
Eur J Ophthalmol; 2016 Apr; 26(3):e46-8. PubMed ID: 26692064
[TBL] [Abstract][Full Text] [Related]
8. Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib.
Rueda-Rueda T; Sánchez-Vicente JL; Moruno-Rodríguez A; Molina-Socola FE; Martínez-Borrego AC; López-Herrero F
Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):458-462. PubMed ID: 29580759
[TBL] [Abstract][Full Text] [Related]
9. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
[TBL] [Abstract][Full Text] [Related]
10. GRAFT-VERSUS-HOST DISEASE PANUVEITIS AND BILATERAL SEROUS DETACHMENTS: MULTIMODAL IMAGING ANALYSIS.
Jung JJ; Chen MH; Rofagha S; Lee SS
Retin Cases Brief Rep; 2017 Winter; 11 Suppl 1():S54-S61. PubMed ID: 27571426
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review.
Yilmaz Tugan B; Ozkan B; Sonmez O
Semin Ophthalmol; 2021 Nov; 36(8):794-799. PubMed ID: 33780309
[No Abstract] [Full Text] [Related]
12. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
Hanna KS
Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
[TBL] [Abstract][Full Text] [Related]
13. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
[No Abstract] [Full Text] [Related]
14. [Bilateral panuveitis with serous retinal detachment].
Ramharter A; Kremser B
Ophthalmologe; 2009 Apr; 106(4):351-5. PubMed ID: 18696078
[TBL] [Abstract][Full Text] [Related]
15. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
16. Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report.
Lambert I; Fasolino G; Awada G; Kuijpers R; Ten Tusscher M; Neyns B
BMC Ophthalmol; 2021 Jun; 21(1):250. PubMed ID: 34090381
[TBL] [Abstract][Full Text] [Related]
17. PEMBROLIZUMAB ADMINISTRATION ASSOCIATED WITH POSTERIOR UVEITIS.
Aaberg MT; Aaberg TM
Retin Cases Brief Rep; 2017 Fall; 11(4):348-351. PubMed ID: 27490976
[TBL] [Abstract][Full Text] [Related]
18. Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab.
Navarro-Perea C; Garcia-Gonzalez J; Perez-Blazquez E
Indian J Ophthalmol; 2019 Dec; 67(12):2075-2077. PubMed ID: 31755465
[TBL] [Abstract][Full Text] [Related]
19. CHOROIDAL NEOVASCULAR MEMBRANES ASSOCIATED WITH PAPILLITIS IN A PATIENT ON CHECKPOINT INHIBITOR.
Xia T; Bracha P; Bhatt N; Aleman T; Brucker A
Retin Cases Brief Rep; 2023 Sep; 17(5):625-629. PubMed ID: 37643053
[TBL] [Abstract][Full Text] [Related]
20. Bilateral multifocal retinal pigment epithelium detachments associated with systemic corticosteroids.
Mendrinos E; Mavrakanas N; Dang-Burgener NP; Pournaras CJ
Eur J Ophthalmol; 2008; 18(4):649-51. PubMed ID: 18609493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
